Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 9 Wilms Tumor 2 Pancreatic Neoplasms 2 Kidney Neoplasms 2 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Paraganglioma 1 Ovarian Neoplasms 1 Neoplastic Syndromes, Hereditary 1 Neoplasm Metastasis 1 Hepatic Veno-Occlusive Disease 1 Genetic Predisposition to Disease 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Docetaxel 35 pembrolizumab 32 Nivolumab 27 enzalutamide 20 Prednisone 20 Sunitinib 16 Cyclophosphamide 16 aldesleukin 14 Zoledronic Acid 13 Interleukin-2 13 Gemcitabine 13 Bevacizumab 13 Specimen Handling 12 Ipilimumab 12 Radiosurgery 11 Everolimus 11 Androgen Antagonists 11 Abiraterone Acetate 11 fludarabine 10 Sorafenib 10 Radiotherapy 10 Paclitaxel 10 Magnetic Resonance Spectroscopy 10 pazopanib 9 abiraterone 9 Doxorubicin 8 Carboplatin 8 Biopsy 8 avelumab 7 temsirolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Genetic Testing × Genitourinary × Clear all

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡